CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma von Advani, Ranjana, Flinn, Ian, Popplewell, Leslie, Forero, Andres, Bartlett, Nancy L, Ghosh, Nilanjan, Kline, Justin, Roschewski, Mark, LaCasce, Ann, Collins, Graham P, Tran, Thu, Lynn, Judith, Chen, James Y, Volkmer, Jens-Peter, Agoram, Balaji, Huang, Jie, Majeti, Ravindra, Weissman, Irving L, Takimoto, Chris H, Chao, Mark P, Smith, Sonali M

Volltext

Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies von Chao, Mark P., Takimoto, Chris H., Feng, Dong Dong, McKenna, Kelly, Gip, Phung, Liu, Jie, Volkmer, Jens-Peter, Weissman, Irving L., Majeti, Ravindra

Volltext

Castration-Resistant Prostate Cancer: Locking Up the Molecular Escape Routes von ATTAR, Ricardo M, TAKIMOTO, Chris H, GOTTARDIS, Marco M

Volltext

Expression of Epiregulin and Amphiregulin and K-ras Mutation Status Predict Disease Control in Metastatic Colorectal Cancer Patients Treated With Cetuximab von KHAMBATA-FORD, Shirin, GARRETT, Christopher R, TAN, Benjamin R, KRISHNAMURTHI, Smitha S, BURRIS, Howard A, POPLIN, Elizabeth A, HIDALGO, Manuel, BASELGA, Jose, CLARK, Edwin A, MAURO, David J, MEROPOL, Neal, BASIK, Mark, HARBISON, Christopher T, SHUJIAN WU, WONG, Tai W, XIN HUANG, TAKIMOTO, Chris H, GODWIN, Andrew K

Volltext

Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas von MAKI, Robert G, D'ADAMO, David R, TAKIMOTO, Chris H, KRAFT, Andrew S, ELIAS, Anthony D, BROCKSTEIN, Bruce, BLACHERE, Nathalie E, EDGAR, Mark A, SCHWARTZ, Lawrence H, QIN, Li-Xuan, ANTONESCU, Cristina R, SCHWARTZ, Gary K, KEOHAN, Mary L, SAULLE, Michael, SCHUETZE, Scott M, UNDEVIA, Samir D, LIVINGSTON, Michael B, COONEY, Matthew M, HENSLEY, Martee L, MITA, Monica M

Volltext

Dietary Genistein Inhibits Metastasis of Human Prostate Cancer in Mice von LAKSHMAN, Minalini, LI XU, ANANTHANARAYANAN, Vijayalakshmi, COOPER, Joshua, TAKIMOTO, Chris H, HELENOWSKI, Irene, PELLING, Jill C, BERGAN, Raymond C

Volltext

A Phase I Study of Eribulin Mesylate (E7389), a Mechanistically Novel Inhibitor of Microtubule Dynamics, in Patients with Advanced Solid Malignancies von Goel, Sanjay, Mita, Alain C, Mita, Monica, Rowinsky, Eric K, Chu, Quincy S, Wong, Nancy, Desjardins, Christopher, Fang, Fang, Jansen, Mendel, Shuster, Dale E, Mani, Sridhar, Takimoto, Chris H

Volltext

Phase I Trial of Sorafenib and Gemcitabine in Advanced Solid Tumors with an Expanded Cohort in Advanced Pancreatic Cancer von SIU, Lillian L, AWADA, Ahmad, TAKIMOTO, Chris H, PICCART, Martine, SCHWARTZ, Brian, GIANNARIS, Tom, LATHIA, Chetan, PETRENCIUC, Oana, MOORE, Malcolm J

Volltext

Phase I and Pharmacologic Study of 17-(Allylamino)-17-Demethoxygeldanamycin in Adult Patients With Solid Tumors von GREM, Jean L, MORRISON, Geraldine, NECKERS, Len, WILSON, Richard H, GUO, Xiao-Du, AGNEW, Elizabeth, TAKIMOTO, Chris H, THOMAS, Rebecca, SZABO, Eva, GROCHOW, Louise, GROLLMAN, Frank, HAMILTON, J. Michael

Volltext

Phase I and Pharmacokinetic Study of Imatinib Mesylate in Patients With Advanced Malignancies and Varying Degrees of Renal Dysfunction: A Study by the National Cancer Institute Org... von GIBBONS, Joseph, EGORIN, Merrill J, PAVLICK, Anna, LENZ, Heinz-Josef, FLICK, Susan M, REYNOLDS, Sherrie, LAGATTUTA, Theodore F, PARISE, Robert A, YANFENG WANG, MURGO, Anthony J, IVY, S. Percy, REMICK, Scot C, RAMANATHAN, Ramesh K, PINGFU FU, MULKERIN, Daniel L, SHIBATA, Stephen, TAKIMOTO, Chris H. M, MANI, Sridhar, LORUSSO, Patricia A, GREM, Jean L

Volltext

Phase I and Pharmacokinetic Study of Imatinib Mesylate in Patients With Advanced Malignancies and Varying Degrees of Liver Dysfunction: A Study by the National Cancer Institute Org... von RAMANATHAN, Ramesh K, EGORIN, Merrill J, POTTER, Douglas M, BELANI, Chandra P, HAYES, Michael J, BIN PENG, IVY, S. Percy, TAKIMOTO, Chris H. M, REMICK, Scot C, DOROSHOW, James H, LORUSSO, Patricia A, MULKERIN, Daniel L, GREM, Jean L, HAMILTON, Anne, MURGO, Anthony J

Volltext

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers von Sikic, Branimir I, Lakhani, Nehal, Patnaik, Amita, Shah, Sumit A, Chandana, Sreenivasa R, Rasco, Drew, Colevas, A Dimitrios, O'Rourke, Timothy, Narayanan, Sujata, Papadopoulos, Kyriakos, Fisher, George A, Villalobos, Victor, Prohaska, Susan S, Howard, Maureen, Beeram, Muralidhar, Chao, Mark P, Agoram, Balaji, Chen, James Y, Huang, Jie, Axt, Matthew, Liu, Jie, Volkmer, Jens-Peter, Majeti, Ravindra, Weissman, Irving L, Takimoto, Chris H, Supan, Dana, Wakelee, Heather A, Aoki, Rhonda, Pegram, Mark D, Padda, Sukhmani K

Volltext

Population pharmacokinetic analysis of oxaliplatin in adults and children identifies important covariates for dosing von Nikanjam, Mina, Stewart, Clinton F., Takimoto, Chris H., Synold, Timothy W., Beaty, Orren, Fouladi, Maryam, Capparelli, Edmund V.

Volltext

Safety and anti-tumor activity of sorafenib (Nexavar®) in combination with other anti-cancer agents: a review of clinical trials von Takimoto, Chris H., Awada, Ahmad

Volltext

Phase I and Pharmacokinetic Study of Pemetrexed Administered Every 3 Weeks to Advanced Cancer Patients With Normal and Impaired Renal Function von MITA, Alain C, SWEENEY, Christopher J, MOLPUS, Kathleen, LATZ, Jane E, SIMMS, Lorinda, CHAUDHARY, Ajai K, JOHNSON, Robert D, ROWINSKY, Eric K, TAKIMOTO, Chris H, BAKER, Sharyn D, GOETZ, Andrew, HAMMOND, Lisa A, PATNAIK, Amita, TOLCHER, Anthony W, VILLAHNA-CALERO, Mtguel, SANDLER, Alan, CHAUDHURI, Tuhin

Volltext

Oxaliplatin Pharmacokinetics and Pharmacodynamics in Adult Cancer Patients with Impaired Renal Function von TAKIMOTO, Chris H, GRAHAM, Martin A, SYNOLD, Timothy W, DOROSHOW, James H, HAMILTON, Anne, MULKERIN, Daniel L, IVY, Percy, EGORIN, Merrill J, GREM, Jean L, LOCKWOOD, Graham, NG, Chee M, GOETZ, Andrew, GREENSLADE, Dennis, REMICK, Scot C, SHARMA, Sunil, MANI, Sridhar, RAMANATHAN, Ramesh K

Volltext

A Phase I and Pharmacokinetic Study of Pegylated Camptothecin as a 1-Hour Infusion Every 3 Weeks in Patients With Advanced Solid Malignancies von ROWINSKY, Eric K, RIZZO, Jinee, DENIS, Louis, MCGUIRE, Jeffrey, TOLCHER, Anthony W, OCHOA, Leonel, TAKIMOTO, Chris H, FOROUZESH, Bahram, SCHWARTZ, Garry, HAMMOND, Lisa A, PATNAIK, Amita, KWIATEK, Joseph, GOETZ, Andrew

Volltext

Phase I Pharmacokinetic and Pharmacodynamic Analysis of Unconjugated Soy Isoflavones Administered to Individuals with Cancer von TAKIMOTO, Chris H, GLOVER, Kira, LLORENS, Victor, LIEBERMAN, Ronald, CROWELL, James A, POISSON, Brett A, BERGAN, Raymond C, HUANG, Xiaoke, HAYES, Steven A, GALLOT, Lilia, QUINN, Mary, JOVANOVIC, Borko D, SHAPIRO, Alla, HERNANDEZ, Leticia, GOETZ, Andrew

Volltext

Phase I and Pharmacokinetic Study of Pemetrexed with High-Dose Folic Acid Supplementation or Multivitamin Supplementation in Patients with Locally Advanced or Metastatic Cancer von TAKIMOTO, Chris H, HAMMOND-THELIN, Lisa A, WOOD, Leslie, SCHNECK, Karen B, CLARK, Romnee, ROWINSKY, Eric K, LATZ, Jane E, FORERO, Leonardo, BEERAM, Muralidhar, FOROUZESH, Bahram, DE BONO, Johann, TOLCHER, Anthony W, PATNAIK, Amita, MONROE, Pamela

Volltext

Dose-Escalating and Pharmacologic Study of Oxaliplatin in Adult Cancer Patients with Impaired Hepatic Function: A National Cancer Institute Organ Dysfunction Working Group Study von SYNOLD, Timothy W, TAKIMOTO, Chris H, LENZ, Heinz Josef, GRAHAM, Martin, LONGMATE, Jeffrey, KAUFMAN, Bennett M, IVY, Percy, DOROSHOW, James H, GANDARA, David, MANI, Sridhar, REMICK, Scot C, MULKERIN, Daniel L, HAMILTON, Anne, SHARMA, Sunil, RAMANATHAN, Ramesh K

Volltext